Chadwick’s appointment — which goes into effect on April 22, 2024 — follows an extensive search process conducted by Insulet. That search spanned nearly six months after former CFO Wayde McMillan left for 3M’s Solventum healthcare spinoff in October.
Lauren Budden served as interim CFO and treasurer following McMillan’s departure. Insulet plans for her to continue in her role as group VP, chief accounting officer and controller.
Chadwick now joins Acton, Massachusetts-based Insulet, a developer of automated insulin delivery technology, with more than 30 years of experience in propelling growth within organizations.
“We are thrilled to welcome Ana to Insulet,” said Jim Hollingshead, Insulet president and CEO. “She is an experienced public company CFO, and her achievements throughout her career demonstrate that she is a proven, highly accomplished, and versatile executive. Ana is known for her insight, intellectual agility, and compelling and collaborative leadership. She will be a strong addition to our leadership team as we continue to scale and expand our business.”
More about the new Insulet CFO
Chadwick currently serves as EVP and CFO at Pitney Bowes, a company using smart technology to enhance mailing solutions. Before her time at Pitney Bowes, Chadwick spent more than 27 years at GE. There, she held a variety of financial and operational posts.
At GE, Chadwick served as CEO and COO of GE Capital Global Legacy Solutions and CFO of GE Capital Energy Financial Services. She also held the position of controller of GE Capital Americas.
Insulet said Chadwick’s experience includes leading large and dynamic finance teams and overseeing financial reporting. She’s driven financial and operational efficiencies across the U.S., Latin America and Europe. The company also expects her to bring a deep understanding of capital markets, business strategy, investor relations and tax policy.
“I am excited to join the Insulet team and help the Company advance its critical mission of improving the lives of people with diabetes,” said Ms. Chadwick. “I look forward to working with Jim and the talented team to build on Insulet’s strong financial foundation, further driving growth, profitability, and value for shareholders.”
